Olema Pharmaceuticals Ownership | Who Owns Olema Pharmaceuticals?

Olema Pharmaceuticals Ownership Summary

Olema Pharmaceuticals is owned by 99.56% institutional investors, 1.76% insiders. Fmr is the largest institutional shareholder, holding 11.81% of OLMA shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.06% of its assets in Olema Pharmaceuticals shares.

OLMA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Olema Pharmaceuticals	99.56%	1.76%	-1.32%
Sector	Healthcare Stocks	244.37%	12.11%	-156.48%
Industry	Biotech Stocks	379.01%	11.75%	-290.76%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	12.14M	11.81%	$151.91M
Paradigm biocapital advisors lp	8.67M	8.43%	$108.47M
Janus henderson group	7.11M	8.17%	$106.01M
Blackrock	4.00M	7.11%	$43.27M
Bain capital life sciences investors	7.09M	6.89%	$88.64M
Blackrock funding, inc. /de	6.71M	6.53%	$84.00M
Bvf inc/il	5.30M	5.15%	$66.25M
Siren	4.86M	4.72%	$60.76M
State street	4.32M	4.20%	$53.99M
Vanguard group	3.56M	4.15%	$89.03M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bain capital life sciences investors	7.09M	5.27%	$88.64M
Paradigm biocapital advisors lp	8.67M	2.03%	$108.47M
Ghost tree capital	550.00K	1.86%	$5.95M
Logos global management lp	3.21M	1.73%	$40.14M
Bvf inc/il	5.30M	1.69%	$66.25M
Kingdon capital management	1.20M	1.54%	$15.01M
Cormorant asset management, lp	2.15M	1.38%	$26.90M
Siren	4.86M	1.23%	$60.76M
Birchview capital, lp	199.00K	1.16%	$2.49M
Vivo capital	671.84K	0.77%	$8.40M

Top Buyers

Holder	Shares	% Assets	Change
Fmr	12.14M	0.01%	1.76M
Deep track capital, lp	1.50M	0.27%	1.50M
Franklin resources	2.35M	0.01%	1.13M
Blackrock funding, inc. /de	6.71M	0.00%	1.06M
Point72 asset management	1.07M	0.01%	999.84K

Top Sellers

Holder	Shares	% Assets	Change
Ra capital management	-	-	-2.60M
Bioimpact capital	-	-	-2.38M
Jennison associates	-	-	-1.82M
Cormorant asset management, lp	2.15M	1.38%	-1.75M
Avoro capital advisors	-	-	-1.65M

New Positions

Holder	Shares	% Assets	Change	Value
Deep track capital, lp	1.50M	0.27%	1.50M	$18.77M
Boxer capital	650.00K	0.37%	650.00K	$7.03M
Readystate asset management lp	593.83K	0.25%	593.83K	$7.43M
Sixth street partners management company	518.34K	0.00%	518.34K	$6.48M
Schroder investment management group	114.19K	0.00%	114.19K	$1.39M

Sold Out

Holder	Change
Hughes financial services	-1.00
Swan capital	-1.00
Activest wealth management	-1.00
Mai capital management	-5.00
Nelson, van denburg & campbell wealth management group	-6.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	197	-10.05%	102,346,731	0.86%	99	0.73%	98	-18.33%	59	11.32%
Mar 31, 2026	217	2.36%	100,923,015	11.23%	115	1.04%	118	-19.18%	53	39.47%
Dec 31, 2025	74	-43.51%	17,589,137	-74.25%	20	0.32%	53	-19.70%	12	-66.67%
Sep 30, 2025	47	-58.77%	11,890,120	-82.11%	13	0.23%	20	-71.43%	15	-37.50%
Jun 30, 2025	119	-10.53%	70,425,751	6.89%	82	1.38%	73	5.80%	25	-43.18%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
State Street® SPDR® S&P® Biotech ETF	2.67M	3.06%	6.14K
Vanguard Total Stock Mkt Idx Inv	2.61M	2.99%	183.90K
Vanguard Morn Total Stk Mkt Idx Investor	2.61M	2.99%	183.90K
Vanguard MStar Total Stk Mkt Idx Invest	2.61M	2.99%	-
iShares Russell 2000 ETF	2.00M	2.29%	-35.52K
Vanguard US Total Market Shares ETF	1.49M	2.18%	-
Polar Capital Healthcare Opports Inc	1.60M	1.84%	-
Fidelity Select Health Care	1.60M	1.83%	100.00K
Strategic Advisers Fidelity US TtlStk	1.42M	1.63%	295.57K
Candriam Global Equities Oncology	860.55K	1.50%	187.55K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 24, 2026	Harmon Cyrus	-	Sell	$146.43K
Jul 23, 2026	Harmon Cyrus	-	Sell	$144.74K
Mar 04, 2026	Mitchell Shawnte	CHIEF LEGAL OFFICER	Sell	$5.75K
Mar 04, 2026	Mitchell Shawnte	CHIEF LEGAL OFFICER	Sell	$600.60K
Mar 03, 2026	Mitchell Shawnte	CHIEF LEGAL OFFICER	Sell	$345.15K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	-	2
2026 Q2	-	-
2026 Q1	-	12
2025 Q4	-	11
2025 Q3	-	4

OLMA Ownership FAQ

Who Owns Olema Pharmaceuticals?

Olema Pharmaceuticals shareholders are primarily institutional investors at 99.56%, followed by 1.76% insiders and -1.32% retail investors. The average institutional ownership in Olema Pharmaceuticals's industry, Biotech Stocks , is 379.01%, which Olema Pharmaceuticals falls below.

Who owns the most shares of Olema Pharmaceuticals?

Olema Pharmaceuticals’s largest shareholders are Fmr (12.14M shares, 11.81%), Paradigm biocapital advisors lp (8.67M shares, 8.43%), and Janus henderson group (7.11M shares, 8.17%). Together, they hold 28.42% of Olema Pharmaceuticals’s total shares outstanding.

Does Blackrock own Olema Pharmaceuticals?

Yes, BlackRock owns 7.11% of Olema Pharmaceuticals, totaling 4M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 43.27M$. In the last quarter, BlackRock increased its holdings by 782.96K shares, a 24.34% change.

Who is Olema Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bain capital life sciences investors is Olema Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 5.27% of its assets in 7.09M Olema Pharmaceuticals shares, valued at 88.64M$.

Who is the top mutual fund holder of Olema Pharmaceuticals shares?

State Street® SPDR® S&P® Biotech ETF is the top mutual fund holder of Olema Pharmaceuticals shares, with 3.06% of its total shares outstanding invested in 2.67M Olema Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools